Navigation Links
Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Date:8/19/2007

NEW HAVEN, Conn., Aug. 15 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: VION) today announced that it had accrued a total of 85 patients to the pivotal Phase II trial of its lead anticancer agent Cloretazine(R) (VNP40101M) in previously untreated elderly patients with de novo poor-risk acute myelogenous leukemia (AML).

Alan Kessman, Chief Executive Officer said, "We are extremely pleased to have reached this milestone in the pivotal Phase II trial of our lead anticancer agent. We will now proceed to analyze the data and, if warranted, prepare a New Drug Application for submission to the U.S. Food and Drug Administration in 2008." He added, "We continue to plan on the release of preliminary data from this trial at the American Society of Hematology (ASH) Meeting in December."

The pivotal Phase II trial, initiated in May 2006, is evaluating Cloretazine(R) (VNP40101M) as a single agent in previously untreated AML patients over the age of 60 with de novo poor-risk AML. Patients are eligible for this trial if they are at least 60 years of age with de novo AML and have one of the following additional risk factors: (i) unfavorable cytogenetics; (ii) an ECOG performance status of 2 or greater; or (iii) a co-morbid condition that precludes them from receiving cytotoxic therapy with cytarabine and an anthracycline. Patients over the age of 70 with de novo AML who do not have favorable cytogenetics are also eligible.

The primary endpoint for this trial is the complete response rate (including complete remission (CR) and complete remission with incomplete platelet recovery (CRp)). Secondary endpoints include overall survival, disease-free survival and progression-free survival.

The trial ha
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...N.Y., Nov. 9 /PRNewswire/ -- On Sept. 11, 2001, ...er rescue workers came together to save as many li...ter Brian McCauley was one of those 9/11 first res...,, Only in his late 30s, McCauley was diagnosed... extensive chemotherapy treatments, leaving him co...
(Date:11/9/2009)...ov. 9 Milestone Scientif... leader in computer-controlled injection technolog...s patented, award-winning STA Single Tooth Anesth...,s 15th year of TBSE titled "The Love Dentistry Fe...lton. ,, The STA System is a computer-contr...
(Date:11/9/2009)... 9 RBC Life Sciences, ...roprietary nutritional supplements and wound care/...e Top 100 workplaces in the Dallas-Fort Worth area...e Top 100 Places to Work 2009 competition surveyed...medium and large firms throughout the DFW metropol...
Breaking Medicine Technology:The SCOOTER Store Surprises 9/11 First Responder & Merrick Firefighter With Power Chair 2The SCOOTER Store Surprises 9/11 First Responder & Merrick Firefighter With Power Chair 3Milestone Scientific to Exhibit at the 15th Anniversary of TBSE (The Best Seminar Ever) in Las Vegas 2RBC Life Sciences Ranked as One of the Top 100 Workplaces in the Dallas-Fort Worth Area 2Over One Thousand Blind Americans to March in Detroit 50418 1Over One Thousand Blind Americans to March in Detroit 50418 2EFT BioTech Holdings Inc s Sea Vessel Completes Inaugural Passenger Voyage Across the Taiwan Strait 12850 1EFT BioTech Holdings Inc s Sea Vessel Completes Inaugural Passenger Voyage Across the Taiwan Strait 12850 2EFT BioTech Holdings Inc s Sea Vessel Completes Inaugural Passenger Voyage Across the Taiwan Strait 12850 3A birds eye view of art 9072 1A birds eye view of art 9072 2
...(ezetimibe) "may,not actually prevent heart attack...lts of the Enhance trial. Typically, patients "tak...astatin), which combines Zetia,with Zocor (simvast...Merck,& Co. and Schering-Plough Corp., Zetia redu... no trial,has been completed yet that has ever sho...
...val rate from,cancer now is lower in older adolesc...children, in part because of a lack of access to c... according to a study by pediatric,oncologists at ...nally, cure rates in children younger than 15 with...0 years, increasing from 60 percent to,approximate...
Other Medicine Technology:Zetia Does Not Reduce Carotid Plaque Size When Added to Zocor 2Children's Hospital Cancer Study Finds Adolescents and Young Adults Don't Get Same Access to Cutting-Edge Treatment as Younger Patients 2Children's Hospital Cancer Study Finds Adolescents and Young Adults Don't Get Same Access to Cutting-Edge Treatment as Younger Patients 3
(Date:11/9/2009)... Studying Genetic Variance Across th...f Genes , (Vocus) Novembe...ies can be extraordinarily valuable when analyzing...enter genetics study that scanned the genomes of...gional differences, Drs. Chao Tian and Michael F. ...
(Date:11/9/2009)...improve letter formation could boost self-esteem, ...thDay News) -- Autistic children are more likely t...ming letters, than those without autism, researche...ged 8 to 13. Half of the study participants had au...ored within the normal range for perceptual reason...
(Date:11/9/2009)...care increases with longer doctor visits, research...ws) -- Family doctors are now taking more time con...n and improving the quality of visits, a new study...ir primary care physicians during office visits in...verall they seemed to receive better care," said D...
(Date:11/9/2009)... Tomorrow may be too late when it co...n, according to TOPS Club, Inc. (Take Off Pounds S...zation. , (Vocus) Novembe...s to preventing or improving a diabetes condition,...sibly), the nonprofit weight-loss support organiza...
(Date:11/9/2009)...ational Comprehensive Cancer Network (NCCN) has po...etails a draft paradigm for near-term comparative ...ting data. The document introduces the NCCN Compar...ed process that compares the risk-versus-benefit o...CCN Clinical Practice Guidelines in Oncology(TM). ...
Breaking Medicine News(10 mins):Health News:News from the November/December Issue of Molecular Medicine 2Health News:Handwriting Skills May Lag in Kids With Autism 2Health News:Doctors Spending More Time Now With Patients 2Health News:Doctors Spending More Time Now With Patients 3Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 2Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 3Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 4
...at the University of Manchester are trying to lear...he adult world is a complicated collection of sigh...ing on as to understand how they cope up with it. ...ys that learning and development is seen as a seri...
...rmone and is already been shown to be associated w...ts that asthma and obesity are related. // Hence i...high levels of a hormone produced by fat cells are...versity of New Mexico School of Medicine in Albuqu...
...r, Malaysia a two-year-old boy dies at the hospita...f the hand, foot and mouth disease (HFMD). // ... Totally the disease has killed about eight people...orge Chan said to the press that the boy passed aw...
...Veterinary Authority (AVA) in Singapore has made a...of ducks from Perak, in Malaysia, with immediate e...de by Malaysia's Department of Veterinary Services...so this ban might cause an interim paucity of duck...
...a gynecologist at the Medway Maritime Hospital in ...t he is left to "twiddle his thumbs" since his hos...at do you do while you wait for the next person to...patients," Dr Penman said. "It's very distressing,...
...f a study appearing in the journal LWT - Food Scie...bage can reduce the risk of Alzheimer’s disease. /... University led the study and have found that red ...'s. The destructive action of amyloid deposit...
Other Medicine News:Health News:Leptin Plays A Vital Role among Female Patients Suffering From Asthma 2
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
Medicine Products: